Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 4 of the 24 sources its claims cite were checked for support.

Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder

Open access
Xu, Haiting, Zheng, Lina, Wang, Leilei, Gao, Huanqin, Wei, Yanyan, Chen, Jingxu · 2023 · Neuropsychiatric Disease and Treatment

Abstract

Background: Inflammation is relevant to the pathophysiology of severe neuropsychiatric disorders, schizophrenia (SCZ) and bipolar disorders (BD). Multiple pathophysiological biomarkers are valuable for the study of inflammatory processes. This study investigated albumin-related biomarkers in SCZ and BD to explore their roles in disease. Methods: A total of 5,577 SCZ, 3442 BD-manic (BD-M) and 1405 BD-depression (BD-D) in acute stage and 5000 health controls (HCs) were enrolled. The differences in these biomarker levels among different groups were compared, and the contributing factors for the occurrence of SCZ, BD, and subgroups of BD were analyzed. Results: Both SCZ and BD exhibit lower prognostic nutritional index (PNI), but higher neutrophil percentage-to-albumin ratio (NPAR) and creatinine-albumin ratio (CRA) compared with HC. Compared with BD-D, BD-M had higher NPAR and platelet-to-albumin ratio (PAR) and lower CRA. In logistic regression, lower prognostic nutritional index (PNI) and higher CRA were associated with both SCZ and BD, while higher NPAR was associated with BD. In the subgroup of BD, higher NPAR, CRA and lower PNI were associated with BD-M; lower PAR, PNI and higher CRA were associated with BD-D. Conclusion: Our study reaffirmed the role of inflammation in the pathophysiology of SCZ and BD. Diagnostic value has been demonstrated in NPAR, PAR, PNI and CRA for BD and SCZ.

Overview

CoChat Summary

TL;DR

In a large retrospective study, acute schizophrenia (SCZ) and bipolar disorder (BD) patients showed lower albumin and prognostic nutritional index (PNI) but higher neutrophil percentage-to-albumin ratio (NPAR) and creatinine–albumin ratio (CRA) than healthy controls. Albumin-related ratios were associated with disease occurrence, with PNI protective and CRA a risk factor for both SCZ and BD.

Key findings

  • Compared with 5,000 healthy controls, both SCZ (n=5,577) and BD (n=4,847) had lower PNI and higher NPAR and CRA after adjusting for age and sex (e.g., PNI F=768.43, P=0.000; NPAR F=318.60, P=0.000; CRA F=410.66, P=0.000).
  • BD-manic (BD-M; n=3,442) had higher NPAR and platelet-to-albumin ratio (PAR) and lower CRA than BD-depression (BD-D; n=1,405). BD-D had lower PAR than both healthy controls and SCZ, and higher NPAR and CRA than SCZ.
  • In logistic regression, lower PNI and higher CRA were associated with both SCZ and BD; higher NPAR was associated with BD. For SCZ, PNI β=−0.183 and CRA β=1.657; for BD, NPAR β=0.370, PNI β=−0.118, and CRA β=1.849.
  • In BD subgroups, higher NPAR, higher CRA, and lower PNI were associated with BD-M; lower PAR, lower PNI, and higher CRA were associated with BD-D (BD-D: PAR β=−0.126, PNI β=−0.148, CRA β=2.031).

Methods

  • Retrospective cross-sectional/case–control study using electronic medical records from Beijing Hui-Long-Guan Hospital from March 15, 2015 to March 15, 2021.
  • Enrolled 5,577 SCZ, 3,442 BD-M, 1,405 BD-D, and 5,000 healthy controls; Han Chinese, aged 18–65, diagnosed by ICD-10 criteria, with exclusions for comorbid psychiatric disorders, inflammatory/immune/antioxidant-affecting somatic diseases, pregnancy/lactation, BMI >29.9 or <18.5 kg/m², heavy smoking, and hepatopathy/nephropathy/anemia.
  • ANCOVA with age and sex as covariates and Bonferroni post hoc tests compared biomarkers; binary logistic regression adjusted for age and sex assessed risk factors, with nomograms combining multiple indicators.

Limitations

  • The paper states that as a retrospective study, certain clinical information was absent, including course of disease, first episode of psychosis, BMI, and disease severity.
  • The paper states that the cross-sectional design lacks causal conclusions between albumin-related parameters and BD or SCZ.
  • The paper states that dietary supplementation and pharmacotherapy information was unreliable and fragmented, so these confounding factors could not be assessed; evident from the text, the study was also single-center and based on acutely admitted inpatients, which may limit generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2147/ndt.s423399

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Risk factors of SCZ nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of SCZ axes to determine the SCZ risk).
Figure 1 Risk factors of SCZ nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of SCZ axes to determine the SCZ risk).CC BY-NC · PubMed Central
Figure 2 Risk factors of BD nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of BD axes to determine the BD risk).
Figure 2 Risk factors of BD nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of BD axes to determine the BD risk).CC BY-NC · PubMed Central
Figure 3 Risk factors of BD-M nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of BD-M axes to determine the BD-M risk).
Figure 3 Risk factors of BD-M nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of BD-M axes to determine the BD-M risk).CC BY-NC · PubMed Central
Figure 4 Risk factors of BD-D nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of BD-D axes to determine the BD-D risk).
Figure 4 Risk factors of BD-D nomogram. (Code of sex, 1: male, 2: female) (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the Risk of BD-D axes to determine the BD-D risk).CC BY-NC · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 14 Not checked · 44 Own results and interpretations

35 more claims

Create a free account to see all 61 claims and to verify the 20 references still open.

See all claims — free account
  • It may state two separate claims as one. 14
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 33 references

Research works printed but not linked: 2

  1. Ritchie, 1999, J Clin Lab Anal, 13, 273, 10.1002/(sici)1098-2825(1999)13:6 · doi:10.1002/(sici)1098-2825(1999)13:6
  2. Onodera, 1984, Nihon Geka Gakkai Zasshi. Japanese, 85, 1001

Cited by

See all 14

Metadata

Authors
Xu, H., Zheng, L., Wang, L., Gao, H., Wei, Y., & Chen, J.
Affiliations
  • Peking University (CN)
  • Liaocheng People's Hospital (CN)
Venue
Neuropsychiatric Disease and Treatment
Published
2023-09
Volume
Volume 19
Pages
2027-2037
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W4387138532
Cited by
13
References
33
Citations by year
2026: 4 · 2025: 6 · 2024: 3
FWCI
2.64
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
albumin, inflammation, schizophrenia, bipolar disorder, manic episodes, depressive episodes, prognostic nutritional index, neutrophil percentage-to-albumin ratio, platelet-to-albumin ratio, biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder. https://app.cochat.ai/papers/10.2147/ndt.s423399
The paper
Xu, H., Zheng, L., Wang, L., Gao, H., Wei, Y., & Chen, J. (2023). Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s423399

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.